 |
human single domain antibody-like protein inhibitor of the chemokine receptor type 4 |
|---|---|
| Trade Name | |
| Orphan Indication | Idiopathic pulmonary fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-11 00:00:00 |
| Sponsor | AdAlta Limited;15/2 Park Drive;Bundoora |
